Signal Advisors Wealth LLC Purchases 173 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Signal Advisors Wealth LLC lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 12.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,594 shares of the medical equipment provider’s stock after purchasing an additional 173 shares during the quarter. Signal Advisors Wealth LLC’s holdings in Intuitive Surgical were worth $832,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Hazlett Burt & Watson Inc. raised its stake in Intuitive Surgical by 5.8% during the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock worth $177,000 after buying an additional 20 shares during the period. Mitchell Mcleod Pugh & Williams Inc. raised its position in shares of Intuitive Surgical by 4.1% during the third quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock worth $247,000 after purchasing an additional 20 shares during the period. Fragasso Financial Advisors Inc lifted its holdings in shares of Intuitive Surgical by 3.0% during the 4th quarter. Fragasso Financial Advisors Inc now owns 687 shares of the medical equipment provider’s stock valued at $359,000 after purchasing an additional 20 shares in the last quarter. Ullmann Wealth Partners Group LLC grew its position in shares of Intuitive Surgical by 1.6% in the 3rd quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock valued at $653,000 after purchasing an additional 21 shares during the period. Finally, Meeder Advisory Services Inc. increased its stake in Intuitive Surgical by 0.3% during the 3rd quarter. Meeder Advisory Services Inc. now owns 7,386 shares of the medical equipment provider’s stock worth $3,629,000 after purchasing an additional 22 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Transactions at Intuitive Surgical

In other news, EVP Brian Edward Miller sold 2,553 shares of the firm’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total transaction of $1,314,795.00. Following the completion of the sale, the executive vice president now owns 7,066 shares in the company, valued at approximately $3,638,990. This trade represents a 26.54 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total transaction of $95,225.76. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,788,899.12. This trade represents a 3.30 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 48,190 shares of company stock worth $25,012,927. 0.90% of the stock is owned by company insiders.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $538.88 on Wednesday. The stock has a market cap of $191.94 billion, a P/E ratio of 86.64, a P/E/G ratio of 5.31 and a beta of 1.39. The company has a fifty day moving average price of $537.05 and a two-hundred day moving average price of $496.50. Intuitive Surgical, Inc. has a one year low of $355.17 and a one year high of $556.23.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The business had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. As a group, equities research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Analyst Ratings Changes

ISRG has been the topic of a number of research reports. Stifel Nicolaus lifted their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the company a “buy” rating in a research note on Thursday, December 5th. Mizuho boosted their price objective on shares of Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Leerink Partners increased their target price on Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Raymond James boosted their price target on Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a report on Monday, October 14th. Finally, Evercore ISI reiterated a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.